Home
>
National Drug Code (NDC)
>
ACYCLOVIR
ACYCLOVIR - 16590-003-35 - (ACYCLOVIR)
Drug Information of ACYCLOVIR
| Product NDC: | 16590-003 |
| Proprietary Name: | ACYCLOVIR |
| Non Proprietary Name: | ACYCLOVIR |
| Active Ingredient(s): | 800 mg/1 & nbsp; ACYCLOVIR |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ACYCLOVIR
| Product NDC: | 16590-003 |
| Labeler Name: | Stat Rx USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074980 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980930 |
Package Information of ACYCLOVIR
| Package NDC: | 16590-003-35 |
| Package Description: | 35 TABLET in 1 BOTTLE (16590-003-35) |
NDC Information of ACYCLOVIR
| NDC Code | 16590-003-35 |
| Proprietary Name | ACYCLOVIR |
| Package Description | 35 TABLET in 1 BOTTLE (16590-003-35) |
| Product NDC | 16590-003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ACYCLOVIR |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19980930 |
| Marketing Category Name | ANDA |
| Labeler Name | Stat Rx USA |
| Substance Name | ACYCLOVIR |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
